Samsung Medical Center

Samsung Medical Center redefines the global limits of the clinical experience by operating as a fully integrated, hyper-digitized ecosystem of healing and scientific innovation. Founded by the Samsung Group, this elite medical titan spans a massive 353,000 square meters across five interconnected structural nodes, including its iconic Main Building, a state-of-the-art oncology center, a dedicated proton therapy center, and the specialized Research Institute for Future Medicine. Upon entering the facility, the traditional, clinical starkness of modern hospitals is entirely erased by a grand, five-story vaulted lobby featuring a live grand piano performance, immediately establishing a sensory-calming environment where humanist empathy directly interfaces with advanced computational medicine. This expansive campus serves as the academic and clinical engine for the Sungkyunkwan University School of Medicine, deploying a powerful workforce of thousands of specialized clinicians, nurses, and molecular researchers who manage a staggering annual volume of millions of outpatient consultations and tens of thousands of complex, high-acuity surgical procedures. The therapeutic vanguard of the institution is anchored by the world-class Samsung Comprehensive Cancer Center and its precision cancer therapeutics center, a multi-omics powerhouse that translates advanced genetic profiling directly into targeted treatment for roughly 10% of all cancer patients nationwide. As a premier global capital for oncological intervention, the hospital commands an unmatched surgical edge in minimally invasive single-port and robot-assisted therapies, utilizing a massive robotic fleet, including the newly integrated next-generation Da Vinci 5 and the single-port Da Vinci SP systems, to rank among the top global institutions for complex genitourinary, thoracic, and colorectal oncology. This cellular and mechanical precision is further driven by the hospital's independent proton therapy unit, which utilizes advanced cyclotron particle accelerators to deliver target-locked, high-dose radiation beams directly into malignant tissues while completely preserving adjacent healthy organs, operating alongside South Korea’s pioneering chimeric antigen receptor CAR-T cell therapy matrix. These oncological breakthroughs are perfectly aligned with the hospital’s heart vascular stroke institute, which combines AI-driven rapid neuroimaging analysis with multidisciplinary cardiology teams to perform intricate artificial heart transplants and immediate endovascular interventions during hyperacute vascular crises. The oncology sector has made significant progress. The application of endoscopic submucosal dissection in precancerous conditions of the stomach is particularly significant. This approach avoids open intervention and the development of malignancy in the future.  Also, oncologists at Samsung Clinic Seoul set a world record: performing 1,800 gastric oncology operations and 1,500 colorectal cancer surgical procedures.  Doctors even have 4 PET-CT scanners, 7 SPECT gamma cameras, and 2 cyclotrons. In addition, the clinic is the sole owner of the second-generation proton therapy equipment, a 32-channel spiral MRI, and a Gamma Knife Icon in Asia. A significant achievement is that UNICEF recognized the medical center with a child-friendly special accreditation. In terms of obtainment, the hospital demonstrates the highest survival rates for premature babies worldwide. The background of neonatologists includes the survival of a premature baby weighing 380 grams. Furthermore, doctors in Korea have the most expertise in treating various disorders, as evidenced by the number of successful operations.  In particular, the list includes 1,000 ECMO procedures, 3,000 microvascular decompression procedures for hemifacial spasm and trigeminal neuralgia, 2,000 kidney transplants, and 1,000 endoscopic brain tumor operations.  This amount of surgical experience also offers patients a unique treatment of cardiovascular diseases thanks to balloon angioplasty for patients with chronic thrombotic pulmonary hypertension. Likewise, Seoul Samsung Hospital occupies a leading position in Korea in extracting electrodes from heart devices using the TightRail tool and implanting the latest-generation HeartMate 3 artificial heart. Samsung Medical Center, at the absolute pinnacle of global digital maturity, became the first healthcare provider in the world to secure the prestigious HIMSS Quadruple Stage 7 validation, sweeping the top tier across the Infrastructure, Electronic Medical Record, Digital Imaging, and Analytics Maturity Adoption Models. This flawless digital core is managed by the Data-based Operation and Communication Center, a revolutionary control hub that creates a real-time virtual "digital twin" of the entire hospital to instantly optimize and deploy clinical resources, personnel, and heavy diagnostic machinery such as MRI arrays based on live patient flow metrics. Pushing this intelligent horizon to its absolute zenith, the hospital’s AI-Powered Smart Ward initiative turns conventional inpatient rooms into fully automated biomedical sanctuaries. Within these advanced spaces, patients enter via secure facial-recognition automatic doors, control their physical climate and review live laboratory diagnostics via voice-activated bedside tablets, and communicate directly with nursing hubs through built-in video-chat systems. Simultaneously, ultra-compact wearable AI telemetry continuously monitors blood pressure and electrocardiogram feeds without interrupting rest, while continuous radar-based sensors monitor patient movement to prevent falls in blind spots.